Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

Clinical Transplantation

Volumn 14, Issue 2, 2000, Pages 136-138

  Sarmiento, Juan M ^a   Dockrell, David H ^b   Schwab, Thomas R ^a   Munn, Stephen R ^a,c   Paya, Carlos V ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Azathioprine; Cytomegalovirus; Ganciclovir; Mycophenolate mofetil

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MORBIDITY; PRIORITY JOURNAL;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; AZATHIOPRINE; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; ENTERITIS; FEMALE; GANCICLOVIR; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; PNEUMONIA, VIRAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0034026538     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2000.140206.x     Document Type: Article

References (8)

1. SOLLINGER HS, DEIERHOI MH, BELZER FO, DIETHELM AG, KAUFFMAN RS. RS-61443-phase I clinical trial and pilot rescue study. Transplantation 1992: 53: 428.
2. MATHEW TH. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadavaric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1998: 65: 1450.
3. SARMIENTO JM, MUNN SR, PAYA CV, VELOSA JA, NGUYEN JH. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study. Clin Transplant 1998: 12 (5): 317-374.
4. LJUNGMAN P, GRIFFITHS P. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin SA, eds. Multidisciplinary Approach to Understanding Cytomegalovirus Disease. Amsterdam: Elsevier Science Publishers, 1993: 233.
5. PLOTKIN SA, STARR SE, FRIEDMAN HM et al. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Int Med 1991: 114: 525.
6. SOLLINGER HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995: 60: 225.
7. LIPSKY JJ. Mycophenolate mofetil. Lancet 1996: 348: 1357.
8. HEEMANN U, AZUMA H, HAMAR P, SCHMID C, TILNEY N, PHILIPP T. Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts. Transplant Immunol 1996: 4: 64.